EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Engineering an indoleamine 2,3-dioxygenase immunotherapy via selective cysteine-to-serine mutations

Jennifer A Simonovich iD, Arun Wanchoo iD, Ryan A Clark iD, Junha Park iD, Ayumi Shigemoto iD, Benjamin G Keselowsky iD, Gregory A Hudalla iD

Molecular Systems Design & Engineering · 2025 · 10 (12) · 1090-1098

DOI: 10.1039/d5me00106d ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Systems Design & Engineering, 2025. Verfasst von Jennifer A Simonovich und 6 weiteren Autor:innen. Beteiligte Einrichtung: J. Crayton Pruitt Family Department of Biomedical Engineering, Herbert Wertheim College of Engineering, University of Florida PO Box 116131 Gainesvil…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NIBIB NIH HHS, NIDDK NIH HHS, NIAID NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Selective cysteine-to-serine mutations improves enzymatic stability and therapeutic efficacy of the immunomodulatory enzyme indoleamine 2,3-dioxygenase.

Autor:innen und Institutionen

  • J. Crayton Pruitt Family Department of Biomedical Engineering, Herbert Wertheim College of Engineering, University of Florida PO Box 116131 Gainesville FL 32610 USA bgk@ufl.edu ghudalla@bme.ufl.edu +1 (352) 392 9791 +1…

ORCID-Profile: Jennifer A Simonovich, Arun Wanchoo, Ryan A Clark, Junha Park, Ayumi Shigemoto, Benjamin G Keselowsky, Gregory A Hudalla

Förderung

  • NIBIB NIH HHS
  • NIDDK NIH HHS
  • NIAID NIH HHS
  • NIDCR NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • National Science Foundation

Zitieren

APA

Simonovich, J. A., Wanchoo, A., Clark, R. A., Park, J., Shigemoto, A., Keselowsky, B. G., & Hudalla, G. A. (2025). Engineering an indoleamine 2,3-dioxygenase immunotherapy via selective cysteine-to-serine mutations. Molecular Systems Design & Engineering, 10(12), 1090-1098. https://doi.org/10.1039/d5me00106d

Vancouver

Simonovich JA, Wanchoo A, Clark RA, Park J, Shigemoto A, Keselowsky BG, et al. Engineering an indoleamine 2,3-dioxygenase immunotherapy via selective cysteine-to-serine mutations. Molecular Systems Design & Engineering. 2025;10(12):1090-1098. doi:10.1039/d5me00106d

BibTeX
@article{Simonovich2025,
  author = {Simonovich, Jennifer A and Wanchoo, Arun and Clark, Ryan A and Park, Junha and Shigemoto, Ayumi and Keselowsky, Benjamin G and Hudalla, Gregory A},
  title = {Engineering an indoleamine 2,3-dioxygenase immunotherapy via selective cysteine-to-serine mutations},
  journal = {Molecular Systems Design & Engineering},
  year = {2025},
  volume = {10},
  number = {12},
  pages = {1090--1098},
  doi = {10.1039/d5me00106d}
}
Kostenlos starten →